Farabi Pharmaceutical (XTEH:DFRB1) FCF Margin %: 0.00% (As of . 20)


What is Farabi Pharmaceutical FCF Margin %?

Farabi Pharmaceutical XTEH:DFRB1 FCF Margin % is 0.00% as of . 20.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Farabi Pharmaceutical's Free Cash Flow for the three months ended in . 20 was IRR0.00 Mil. Farabi Pharmaceutical's Revenue for the three months ended in . 20 was IRR0.00 Mil. Therefore, Farabi Pharmaceutical's FCF Margin % for the quarter that ended in . 20 was 0.00%.

As of today, Farabi Pharmaceutical's current FCF Yield % is 0.00%.

The historical rank and industry rank for Farabi Pharmaceutical's FCF Margin % or its related term are showing as below:


XTEH:DFRB1's FCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.48
* Ranked among companies with meaningful FCF Margin % only.

Farabi Pharmaceutical FCF Margin % Related Terms

Farabi Pharmaceutical FCF Margin % Historical Data

* Premium members only.

The historical data trend for Farabi Pharmaceutical's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farabi Pharmaceutical FCF Margin % Chart

Farabi Pharmaceutical Annual Data
Trend
FCF Margin %

Farabi Pharmaceutical Quarterly Data
FCF Margin %

XTEH:DFRB1 vs IMNPQ, INNV: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Farabi Pharmaceutical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Farabi Pharmaceutical FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Farabi Pharmaceutical's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Farabi Pharmaceutical's FCF Margin % falls into.


Farabi Pharmaceutical FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Farabi Pharmaceutical's FCF Margin for the fiscal year that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (A: . 20 )/Revenue (A: . 20 )
=/
= %

Farabi Pharmaceutical's FCF Margin for the quarter that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Farabi Pharmaceutical (XTEH:DFRB1) has a FCF Margin % of 0.00% as of . 20. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Farabi Pharmaceutical and its competitors.
Is Farabi Pharmaceutical's FCF Margin % too high?
Farabi Pharmaceutical's current FCF Margin % is 0.00%.
How does Farabi Pharmaceutical's FCF Margin % compare to IMNPQ and INNV?
Farabi Pharmaceutical's FCF Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median FCF Margin % is 2.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.48, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Farabi Pharmaceutical and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Farabi Pharmaceutical's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farabi Pharmaceutical stock overvalued right now?
Farabi Pharmaceutical (XTEH:DFRB1) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Farabi Pharmaceutical (XTEH:DFRB1), the current FCF Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Farabi Pharmaceutical Business Description

Address South Kheradmand, No. 45, First Floor, Tehran, IRN, 1584853114
Farabi Pharmaceutical is a pharmaceutical company based in Iran. It produces various oral antibiotic-related and non-antibiotic products and dietary supplements. The company develops anti-migraine, antivirals, cholesterol, diabetic, cardiovascular, gastrointestinal, neuroleptics, anti-prostatic and anti-inflammatory and pain release drugs. It offers products in the form of tablet, capsule and suspensions which include Amoxicillin, Cefixime, Azithromycin, Ciprofloxacin, Nitroglycerin, Repaglinide, Orlistat, Domperidone, among others.